Stay updated on TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial page.

Latest updates to the TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1 from the Study Documents section.SummaryDifference0.1%

- Check19 days agoChange DetectedThe changes show a minor revision label update, adding Revision: v3.4.1 and removing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedResults First Posted and Last Update Posted now show actual dates (2025-11-10) in the Study Record Dates section, replacing the previously estimated values; the estimated fields were removed.SummaryDifference0.3%

- Check41 days agoChange DetectedThe page now displays Revision: v3.3.4 and the previous Revision: v3.3.3 entry was removed.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded a Locations section with California as a location; removed HHS Vulnerability Disclosure and California Locations; updated page revision from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check91 days agoChange DetectedThis change adds a new revision tag 'Revision: v3.3.2' and removes 'Revision: v3.2.0' from the page footer. No study content, eligibility criteria, or results are altered.SummaryDifference0.1%

Stay in the know with updates to TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial page.